Re-orienting the immune system: Durable tumor regression and successful re-induction therapy using anti-PD1 antibodies

por Lipson, Evan J.
Publicado 2013

Immunotherapy for Merkel cell carcinoma: a turning point in patient care

por Chan, Isaac S., Bhatia, Shailender, Kaufman, Howard L., Lipson, Evan J.
Publicado 2018

Acute axillary lymphadenopathy detected shortly after COVID-19 vaccination found to be due to newly diagnosed metastatic melanoma

por Gullotti, David M, Lipson, Evan J, Fishman, Elliot K, Rowe, Steven P
Publicado 2022

A Patient with HIV Treated with Ipilimumab and Stereotactic Radiosurgery for Melanoma Metastases to the Brain

por Ruzevick, Jacob, Nicholas, Sarah, Redmond, Kristin, Kleinberg, Lawrence, Lipson, Evan J., Lim, Michael
Publicado 2013

A Case Report of Primary Recurrent Malignant Melanoma of the Urinary Bladder

por Truong, Hong, Sundi, Debasish, Sopko, Nikolai, Xing, Dongmei, Lipson, Evan J., Bivalacqua, Trinity J.
Publicado 2013

Colonic ulcerations may predict steroid-refractory course in patients with ipilimumab-mediated enterocolitis

por Jain, Animesh, Lipson, Evan J, Sharfman, William H, Brant, Steven R, Lazarev, Mark G
Publicado 2017

Immune-mediated ototoxicity associated with immune checkpoint inhibitors in patients with melanoma

por Rosner, Samuel, Agrawal, Yuri, Sun, Daniel Q, Aygun, Nafi, Schollenberger, Megan D, Lipson, Evan, Naidoo, Jarushka
Publicado 2020

How many brain metastases can be treated with stereotactic radiosurgery before the radiation dose delivered to normal brain tissue rivals that associated with standard whole brain...

por Becker, Stewart J., Lipson, Evan J., Jozsef, Gabor, Molitoris, Jason K., Silverman, Joshua S., Presser, Joseph, Kondziolka, Douglas
Publicado 2023

Safety and efficacy of ipilimumab to treat advanced melanoma in the setting of liver transplantation

por Morales, Rita E, Shoushtari, Alexander N, Walsh, Michelle M, Grewal, Priya, Lipson, Evan J, Carvajal, Richard D
Publicado 2015

Circulating tumor DNA analysis as a real-time method for monitoring tumor burden in melanoma patients undergoing treatment with immune checkpoint blockade

por Lipson, Evan J, Velculescu, Victor E, Pritchard, Theresa S, Sausen, Mark, Pardoll, Drew M, Topalian, Suzanne L, Diaz, Luis A
Publicado 2014

Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade

por Lipson, Evan J., Lilo, Mohammed T., Ogurtsova, Aleksandra, Esandrio, Jessica, Xu, Haiying, Brothers, Patricia, Schollenberger, Megan, Sharfman, William H., Taube, Janis M.
Publicado 2017

Utility of Serial Donor-derived Cell-free DNA Measurements for Detecting Allograft Rejection in a Kidney Transplant Recipient After PD-1 Checkpoint Inhibitor Administration

por Lakhani, Laila, Alasfar, Sami, Bhalla, Anshul, Aala, Amtul, Rosenberg, Avi, Ostrander, Darin, Schollenberger, Megan D., Brennan, Daniel C., Lipson, Evan J.
Publicado 2021

Measurement of PD-L1 in melanoma: a quantitative antibody comparison

por Sunshine, Joel C, Berry, Sneha, Esandrio, Jessica, Xu, Haiying, Ogurtsova, Aleksandra, Cornish, Toby, Lipson, Evan J, Anders, Robert A, Taube, Janis M
Publicado 2015

2568 Pembrolizumab for patients with leptomeningeal disease from advanced solid tumors

por Naidoo, Jarushka, Hu, Chen, Schrek, Karisa, Connolly, Roisin, Santa-Maria, Cesar, Lipson, Evan, Mehra, Ranee, Bettegowda, Redmond, Kristin, Venkatesan, Arun, Grossman, Stuart
Publicado 2018

Rescue therapy for patients with anti-PD-1-refractory Merkel cell carcinoma: a multicenter, retrospective case series

por LoPiccolo, Jaclyn, Schollenberger, Megan D., Dakhil, Sumia, Rosner, Samuel, Ali, Osama, Sharfman, William H., Silk, Ann W., Bhatia, Shailender, Lipson, Evan J.
Publicado 2019

Anti-RA33 antibodies are present in a subset of patients with immune checkpoint inhibitor-induced inflammatory arthritis

por Cappelli, Laura C, Bingham, Clifton O, Forde, Patrick M, Anagnostou, Valsamo, Brahmer, Julie, Lipson, Evan J, Mammen, Jennifer, Schollenberger, Megan, Shah, Ami A, Darrah, Erika
Publicado 2022

Adjuvant radiotherapy and outcomes of presumed hemorrhagic melanoma brain metastases without malignant cells

por Xia, Yuanxuan, Mashouf, Leila A., Maxwell, Russell, Peng, Luke C., Lipson, Evan J., Sharfman, William H., Bettegowda, Chetan, Redmond, Kristin J., Kleinberg, Lawrence R., Lim, Michael
Publicado 2018

Melanoma metastatic to the hyoid bone

por Ryan, John F., Xie, Deborah X., Eytan, Danielle F., McCarthy, Edward F., Mandal, Rajarsi, Gourin, Christine G., Lipson, Evan J., Meyer, Christian F., Vosler, Peter S.
Publicado 2020

Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy

por Heinzerling, Lucie, Ott, Patrick A., Hodi, F. Stephen, Husain, Aliya N., Tajmir-Riahi, Azadeh, Tawbi, Hussein, Pauschinger, Matthias, Gajewski, Thomas F., Lipson, Evan J., Luke, Jason J.
Publicado 2016

Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series

por Moseley, Kendall F., Naidoo, Jarushka, Bingham, Clifton O., Carducci, Michael A., Forde, Patrick M., Gibney, Geoffrey T., Lipson, Evan J., Shah, Ami A., Sharfman, William H., Cappelli, Laura C.
Publicado 2018